• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用重组质粒研究人巨细胞病毒基因组的结构。

Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome.

作者信息

Oram J D, Downing R G, Akrigg A, Dollery A A, Duggleby C J, Wilkinson G W, Greenaway P J

出版信息

J Gen Virol. 1982 Mar;59(Pt 1):111-29. doi: 10.1099/0022-1317-59-1-111.

DOI:10.1099/0022-1317-59-1-111
PMID:6279770
Abstract

Human cytomegalovirus (HCMV) DNA was digested with restriction endonucleases and the fragments characterized with respect to molecular weight and relative mole proportions. The terminal fragments were identified by digesting HCMV DNA with exonucleases before restriction endonuclease treatment and subsequent gel analysis. The HindIII fragments of HCMV DNA were cloned in Escherichia coli and recombinant plasmids were characterized by digestion with restriction endonucleases and by molecular hybridization with HindIII, Bg/II and XbaI fragments of the virus genome. Data from these experiments were used to construct physical maps of HCMV DNA for the HindIII, Bg/II and XbaI restriction endonucleases. The terminal regions of the genome and the region containing fragment HindIII M were shown to be heterogeneous.

摘要

用人巨细胞病毒(HCMV)DNA进行限制性核酸内切酶消化,并对片段的分子量和相对摩尔比例进行表征。通过在限制性核酸内切酶处理和随后的凝胶分析之前用核酸外切酶消化HCMV DNA来鉴定末端片段。将HCMV DNA的HindIII片段克隆到大肠杆菌中,通过用限制性核酸内切酶消化以及与病毒基因组的HindIII、Bg/II和XbaI片段进行分子杂交来表征重组质粒。这些实验的数据用于构建针对HindIII、Bg/II和XbaI限制性核酸内切酶的HCMV DNA物理图谱。基因组的末端区域和包含片段HindIII M的区域显示为异质性的。

相似文献

1
Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome.利用重组质粒研究人巨细胞病毒基因组的结构。
J Gen Virol. 1982 Mar;59(Pt 1):111-29. doi: 10.1099/0022-1317-59-1-111.
2
Demonstration of the colinearity of human cytomegalovirus genomes and construction of restriction maps of unknown isolates using cloned subgenomic fragments.人巨细胞病毒基因组共线性的证明以及使用克隆的亚基因组片段构建未知分离株的限制性图谱。
J Gen Virol. 1985 Oct;66 ( Pt 10):2183-98. doi: 10.1099/0022-1317-66-10-2183.
3
Molecular cloning and physical mapping of murine cytomegalovirus DNA.小鼠巨细胞病毒DNA的分子克隆与物理图谱分析
J Virol. 1983 Sep;47(3):421-33. doi: 10.1128/JVI.47.3.421-433.1983.
4
Cloning of the human cytomegalovirus genome as endonuclease XbaI fragments.将人巨细胞病毒基因组克隆为核酸内切酶XbaI片段。
Gene. 1981 Dec;16(1-3):207-16. doi: 10.1016/0378-1119(81)90077-9.
5
Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI.人巨细胞病毒DNA:限制性内切酶BglII、hindIII和XbaI的物理图谱。
J Gen Virol. 1980 Jul;49(1):1-21. doi: 10.1099/0022-1317-49-1-1.
6
Comparison of the physical maps of the DNAs of two cytomegalovirus strains.两种巨细胞病毒株DNA物理图谱的比较。
J Gen Virol. 1983 Jan;64 (Pt 1):47-55. doi: 10.1099/0022-1317-64-1-47.
7
Molecular cloning and restriction endonuclease mapping of the rat cytomegalovirus genome.大鼠巨细胞病毒基因组的分子克隆与限制性内切酶图谱分析
J Gen Virol. 1986 Jul;67 ( Pt 7):1327-42. doi: 10.1099/0022-1317-67-7-1327.
8
Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping.通过分子克隆和物理图谱分析豚鼠巨细胞病毒基因组
J Virol. 1984 Nov;52(2):436-47. doi: 10.1128/JVI.52.2.436-447.1984.
9
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain).小鼠巨细胞病毒基因组(史密斯株)的分子克隆与限制性内切酶图谱分析
Virology. 1983 Aug;129(1):94-106. doi: 10.1016/0042-6822(83)90398-7.
10
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII.人巨细胞病毒AD169株DNA经限制性内切酶EcoRI、BglII和HindIII切割后的酶切图谱。
J Virol. 1982 May;42(2):558-82. doi: 10.1128/JVI.42.2.558-582.1982.

引用本文的文献

1
Human cytomegalovirus: taking the strain.人类巨细胞病毒:应对毒株
Med Microbiol Immunol. 2015 Jun;204(3):273-84. doi: 10.1007/s00430-015-0411-4. Epub 2015 Apr 17.
2
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation.两种新型人类巨细胞病毒自然杀伤细胞逃避功能靶向MICA进行溶酶体降解。
PLoS Pathog. 2014 May 1;10(5):e1004058. doi: 10.1371/journal.ppat.1004058. eCollection 2014 May.
3
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169.人巨细胞病毒毒株汤氏株和AD169株变体的高通量序列分析
J Gen Virol. 2009 Oct;90(Pt 10):2375-2380. doi: 10.1099/vir.0.013250-0. Epub 2009 Jun 24.
4
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome.重新评估人巨细胞病毒AD169株基因组UL42 - UL43区域的组织架构。
Virology. 1997 Dec 8;239(1):169-75. doi: 10.1006/viro.1997.8875.
5
The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43.已公布的人巨细胞病毒AD169株的DNA序列缺少929个碱基对,这些碱基对影响UL42和UL43基因。
J Virol. 1997 Dec;71(12):9833-6. doi: 10.1128/JVI.71.12.9833-9836.1997.
6
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.人类巨细胞病毒US6糖蛋白抑制与抗原加工相关的转运体依赖性肽易位。
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6904-9. doi: 10.1073/pnas.94.13.6904.
7
Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.人类巨细胞病毒US2使主要组织相容性复合体I类重链不稳定。
J Virol. 1997 Apr;71(4):2970-9. doi: 10.1128/JVI.71.4.2970-2979.1997.
8
Assembly of herpes simplex virus capsids using the human cytomegalovirus scaffold protein: critical role of the C terminus.利用人巨细胞病毒支架蛋白组装单纯疱疹病毒衣壳:C末端的关键作用
J Virol. 1997 Feb;71(2):1281-91. doi: 10.1128/JVI.71.2.1281-1291.1997.
9
Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.人巨细胞病毒UL80编码蛋白酶的表达与分析:自蛋白水解位点的鉴定
J Virol. 1993 Jan;67(1):497-506. doi: 10.1128/JVI.67.1.497-506.1993.
10
Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication.人巨细胞病毒oriLyt依赖性DNA复制的瞬时互补需要11个编码反式作用因子的基因座。
J Virol. 1993 Dec;67(12):6979-88. doi: 10.1128/JVI.67.12.6979-6988.1993.